Sezolamide: Additivity to timolol twice daily

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Eye

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/eye.1992.111PMID 1286720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carbonic anhydrase inhibitors for the treatment of glaucoma

  2023cited by this paper
• Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure.

  2009cited by this paper
• Multiple-dose, dose-response relationship for the topical carbonic anhydrase inhibitor MK-927.

  1991cited by this paper
• Multiple-dose efficacy comparison of the two topical carbonic anhydrase inhibitors sezolamide and MK-927.

  1991cited by this paper
• Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK‐927 and sezolamide during two‐week ocular administration to normal subjects

  1991cited by this paper
• Zur Stereospezifität der Augendrucksenkung eines lokal applizierten Karbonhydrasehemmers

  1990cited by this paper
• [Stereospecificity of lowering intraocular pressure using a locally administered carbonic anhydrase inhibitor].

  1990cited by this paper
• MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action.

  1990cited by this paper
• MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility.

  1990cited by this paper
• A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.

  1990cited by this paper
• MK-927: a topically effective carbonic anhydrase inhibitor in patients.

  1989cited by this paper
• Carbonic anhydrase: General perspective and advances in glaucoma research

  1987cited by this paper
• Betaxolol and acetazolamide. Combined ocular hypotensive effect.

  1984cited by this paper
• Timolol and acetazolamide. A study of concurrent administration.

  1982cited by this paper
• The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects.

  1982cited by this paper
• Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma.

  1981cited by this paper
• TIMOLOL VERSUS PILOCARPINE SEPARATELY OR COMBINED WITH ACETAZOLAMIDE‐EFFECTS ON INTRAOCULAR PRESSURE

  1980cited by this paper
• The intraocular pressure responses of low-dose bupranolol (Ophtorenin®) and Methazolamide (Neptazane®) in glaucomatous eyes

  1979cited by this paper
• [Timolol and acetazolamide in the treatment of increased intraocular pressure (author's transl)].

  1979cited by this paper
• Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma.

  1979cited by this paper
• The mechanism of timolol in lowering intraocular pressure. In the normal eye.

  1978cited by this paper
• [Experiences with timolol in treatment of glaucoma (author's transl)].

  1978cited by this paper
• Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

  1978cited by this paper
• A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics.

  1978cited by this paper
• Timolol and facility of outflow.

  1977cited by this paper
• Comparison of ocular hypotensive effects of acetazolamide and atenolol.

  1977cited by this paper
• Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution.

  1976cited by this paper
• The rates of movement of Na+, Cl-, and HCO-3 from plasma to posterior chamber: effect of acetazolamide and relation to the treatment of glaucoma.

  1976cited by this paper
• Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report.

  1954cited by this paper

• Novel approaches for topical delivery of acetazolamide

  2002cites this paper
• Novel Approaches for Topical Delivery of

  2002cites this paper
• The Short-Term Effect of Adding Brimonidine 0.2% to Timolol Treatment in Patients with Open-Angle Glaucoma

  1999cites this paper
• Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.

  1997cites this paper
• Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.

  1993cites this paper
• Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: A multiple-dose efficacy study

  1993cites this paper